Press Releases Years when articles were posted All Years 2026 (4) 2025 (5) 2024 (15) 2023 (10) 2022 (16) 2021 (9) 2020 (1) July 16, 2026 Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV400, the Industry’s First Known CD22-Directed In Vivo CAR T Cell Therapy for Relapsed/Refractory B Cell Malignancies April 27, 2026 Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting March 23, 2026 Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors March 6, 2026 Umoja Biopharma Honors the Life and Legacy of Scientific Co-founder Dr. Philip Low September 30, 2025 Umoja Biopharma Announces that UB-VV111 Receives FDA Fast Track Designation for Relapsed/Refractory B-Cell Malignancies
